|
1
|
Lee WM, Squires RH Jr, Nyberg SL, Doo E
and Hoofnagle JH: Acute liver failure: Summary of a workshop.
Hepatology. 47:1401–1415. 2008.PubMed/NCBI
|
|
2
|
Kung JW and Forbes SJ: Stem cells and
liver repair. Curr Opin Biotechnol. 20:568–574. 2009. View Article : Google Scholar
|
|
3
|
Oertel M and Shafritz DA: Stem cells, cell
transplantation and liver repopulation. Biochim Biophys Acta.
1782:61–74. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Locke JE, Shamblott MJ and Cameron AM:
Stem cells and the liver: clinical applications in transplantation.
Adv Surg. 43:35–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salama H, Zekri AR, Zern M, et al:
Autologous hematopoietic stem cell transplantation in 48 patients
with end-stage chronic liver diseases. Cell Transplant.
19:1475–1486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mark AL, Sun Z, Warren DS, et al: Stem
cell mobilization is life saving in an animal model of acute liver
failure. Ann Surg. 252:591–596. 2010.PubMed/NCBI
|
|
7
|
Antoniades CG, Berry PA, Wendon JA and
Vergani D: The importance of immune dysfunction in determining
outcome in acute liver failure. J Hepatol. 49:845–861. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stuart WD, Kulkarni RM, Gray JK,
Vasiliauskas J, Leonis MA and Waltz SE: Ron receptor regulates
Kupffer cell-dependent cytokine production and hepatocyte survival
following endotoxin exposure in mice. Hepatology. 53:1618–1628.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: controlled demolition at the cellular level. Nat Rev Mol
Cell Biol. 9:231–241. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malhi H, Guicciardi ME and Gores GJ:
Hepatocyte death: a clear and present danger. Physiol Rev.
90:1165–1194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sulahian TH, Hintz KA, Wardwell K and
Guyre PM: Development of an ELISA to measure soluble CD163 in
biological fluids. J Immunol Methods. 252:25–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hiraoka A, Horiike N, Akbar SM, Michitaka
K, Matsuyama T and Onji M: Soluble CD163 in patients with liver
diseases: very high levels of soluble CD163 in patients with
fulminant hepatic failure. J Gastroenterol. 40:52–56. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sulahian TH, Högger P, Wahner AE, et al:
Human monocytes express CD163, which is upregulated by IL-10 and
identical to p155. Cytokine. 12:1312–1321. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pae HO and Chung HT: Heme oxygenase-l: its
therapeutic roles in inflammatory diseases. Immune Netw. 9:12–19.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buechler C, Ritter M, Orsó E, Langmann T,
Klucken J and Schmitz G: Regulation of scavenger receptor CD163
expression in human monocytes and macrophages by pro- and
antiinflammatory stimuli. J Leukoc Biol. 67:97–103. 2000.PubMed/NCBI
|
|
16
|
Parekkadan B, van Poll D, Suganuma K,
Carter EA, Berthiaume F, Tilles AW and Yarmush ML: Mesenchymal stem
cell-derived molecules reverse fulminant hepatic failure. PLoS One.
2:e9412007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo TK, Hung SP, Chuang CH, et al: Stem
cell therapy for liver disease: parameters governing the success of
using bone marrow mesenchymal stem cells. Gastroenterology.
134:2111–2121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ismail A, Fouad O, Abdelnasser A,
Chowdhury A and Selim A: Stem cell therapy improves the outcome of
liver resection in cirrhotics. J Gastrointest Cancer. 41:17–23.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stutchfield BM, Forbes SJ and Wigmore SJ:
Prospects for stem cell transplantation in the treatment of hepatic
disease. Liver Transpl. 16:827–836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cho KA, Ju SY, Cho SJ, et al: Mesenchymal
stem cells showed the highest potential for the regeneration of
injured liver tissue compared with other subpopulations of the bone
marrow. Cell Biol Int. 33:772–777. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enns GM and Millan MT: Cell-based
therapies for metabolic liver disease. Mol Genet Metab. 95:3–10.
2008. View Article : Google Scholar
|
|
22
|
Miyazaki M, Hardjo M, Masaka T, et al:
Isolation of a bone marrow-derived stem cell line with high
proliferation potential and its application for preventing acute
fatal liver failure. Stem Cells. 25:2855–2863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sensebé L and Bourin P: Mesenchymal stem
cells for therapeutic purposes. Transplantation. 87(9 Suppl):
S49–S53. 2009.
|
|
24
|
Miura M, Miura Y, Padilla-Nash HM, et al:
Accumulated chromosomal instability in murine bone marrow
mesenchymal stem cells leads to malignant transformation. Stem
Cells. 24:1095–1103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu F, Liu ZD, Wu N, Cong X, Fei R, Chen
HS and Wei L: Transplanted endothelial progenitor cells ameliorate
carbon tetrachloride-induced liver cirrhosis in rats. Liver
Transpl. 15:1092–1100. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muraca M: Evolving concepts in cell
therapy of liver disease and current clinical perspectives. Dig
Liver Dis. 43:180–187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rust C and Gores GJ: Apoptosis and liver
disease. Am J Med. 108:567–574. 2000. View Article : Google Scholar
|
|
28
|
Ortiz LA, Dutreil M, Fattman C, Pandey AC,
Torres G, Go K and Phinney DG: Interleukin 1 receptor antagonist
mediates the antiinflammatory and antifibrotic effect of
mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA.
104:11002–11007. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Møller HJ, Frikke-Schmidt R, Moestrup SK,
Nordestgaard BG and Tybjærg-Hansen A: Serum soluble CD163 predicts
risk of type 2 diabetes in the general population. Clin Chem.
57:291–297. 2011.PubMed/NCBI
|
|
30
|
Louis H, Le Moine O, Peny MO, et al:
Hepatoprotective role of interleukin 10 in
galactosamine/lipopolysaccharide mouse liver injury.
Gastroenterology. 112:935–942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Philippidis P, Mason JC, Evans BJ, Nadra
I, Taylor KM, Haskard DO and Landis RC: Hemoglobin scavenger
receptor CDl63 mediates interleukin-10 release and heme oxygenase-1
synthesis: antiinflammatory monocyte-macrophage responses in
vitro, in resolving skin blisters in vivo, and after
cardiopulmonary bypass surgery. Circ Res. 94:119–126. 2004.
View Article : Google Scholar
|
|
32
|
Fabriek BO, van Bruggen R, Deng DM, et al:
The macrophage scavenger receptor CD163 functions as an innate
immune sensor for bacteria. Blood. 113:887–892. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moreno JA, Muñoz-García B, Martín-Ventura
JL, et al: The CD163-expressing macrophages recognize and
internalize TWEAK: potential consequences in atherosclerosis.
Atherosclerosis. 207:103–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
